240 related articles for article (PubMed ID: 30089152)
1. Prion acute synaptotoxicity is largely driven by protease-resistant PrPSc species.
Foliaki ST; Lewis V; Finkelstein DI; Lawson V; Coleman HA; Senesi M; Islam AMT; Chen F; Sarros S; Roberts B; Adlard PA; Collins SJ
PLoS Pathog; 2018 Aug; 14(8):e1007214. PubMed ID: 30089152
[TBL] [Abstract][Full Text] [Related]
2. Early existence and biochemical evolution characterise acutely synaptotoxic PrPSc.
Foliaki ST; Lewis V; Islam AMT; Ellett LJ; Senesi M; Finkelstein DI; Roberts B; Lawson VA; Adlard PA; Collins SJ
PLoS Pathog; 2019 Apr; 15(4):e1007712. PubMed ID: 30970042
[TBL] [Abstract][Full Text] [Related]
3. PrPSc Oligomerization Appears Dynamic, Quickly Engendering Inherent M1000 Acute Synaptotoxicity.
Foliaki ST; Lewis V; Islam AMT; Senesi M; Finkelstein DI; Ellett LJ; Lawson VA; Adlard PA; Roberts BR; Collins SJ
Biophys J; 2020 Jul; 119(1):128-141. PubMed ID: 32562618
[TBL] [Abstract][Full Text] [Related]
4. Protease resistance of infectious prions is suppressed by removal of a single atom in the cellular prion protein.
Leske H; Hornemann S; Herrmann US; Zhu C; Dametto P; Li B; Laferriere F; Polymenidou M; Pelczar P; Reimann RR; Schwarz P; Rushing EJ; Wüthrich K; Aguzzi A
PLoS One; 2017; 12(2):e0170503. PubMed ID: 28207746
[TBL] [Abstract][Full Text] [Related]
5. Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease.
Pan T; Wong P; Chang B; Li C; Li R; Kang SC; Wisniewski T; Sy MS
J Virol; 2005 Jan; 79(2):934-43. PubMed ID: 15613322
[TBL] [Abstract][Full Text] [Related]
6. Modulation of proteinase K-resistant prion protein in cells and infectious brain homogenate by redox iron: implications for prion replication and disease pathogenesis.
Basu S; Mohan ML; Luo X; Kundu B; Kong Q; Singh N
Mol Biol Cell; 2007 Sep; 18(9):3302-12. PubMed ID: 17567949
[TBL] [Abstract][Full Text] [Related]
7. Increased proportions of C1 truncated prion protein protect against cellular M1000 prion infection.
Lewis V; Hill AF; Haigh CL; Klug GM; Masters CL; Lawson VA; Collins SJ
J Neuropathol Exp Neurol; 2009 Oct; 68(10):1125-35. PubMed ID: 19918124
[TBL] [Abstract][Full Text] [Related]
8. Proteinase K-sensitive disease-associated ovine prion protein revealed by conformation-dependent immunoassay.
Thackray AM; Hopkins L; Bujdoso R
Biochem J; 2007 Jan; 401(2):475-83. PubMed ID: 17018021
[TBL] [Abstract][Full Text] [Related]
9. Prion protein conversion in vitro.
Supattapone S
J Mol Med (Berl); 2004 Jun; 82(6):348-56. PubMed ID: 15014886
[TBL] [Abstract][Full Text] [Related]
10. Prions activate a p38 MAPK synaptotoxic signaling pathway.
Fang C; Wu B; Le NTT; Imberdis T; Mercer RCC; Harris DA
PLoS Pathog; 2018 Sep; 14(9):e1007283. PubMed ID: 30235355
[TBL] [Abstract][Full Text] [Related]
11. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.
Norstrom EM; Mastrianni JA
J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252
[TBL] [Abstract][Full Text] [Related]
12. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
13. Generating a prion with bacterially expressed recombinant prion protein.
Wang F; Wang X; Yuan CG; Ma J
Science; 2010 Feb; 327(5969):1132-5. PubMed ID: 20110469
[TBL] [Abstract][Full Text] [Related]
14. Quaternary Structure Changes for PrP
Eskandari-Sedighi G; Cortez LM; Yang J; Daude N; Shmeit K; Sim V; Westaway D
Mol Neurobiol; 2021 Jan; 58(1):375-390. PubMed ID: 32959170
[TBL] [Abstract][Full Text] [Related]
15. Use of thermolysin in the diagnosis of prion diseases.
Owen JP; Maddison BC; Whitelam GC; Gough KC
Mol Biotechnol; 2007 Feb; 35(2):161-70. PubMed ID: 17435282
[TBL] [Abstract][Full Text] [Related]
16. Pressure-assisted dissociation and degradation of "proteinase K-resistant" fibrils prepared by seeding with scrapie-infected hamster prion protein.
Akasaka K; Maeno A; Murayama T; Tachibana H; Fujita Y; Yamanaka H; Nishida N; Atarashi R
Prion; 2014; 8(4):314-8. PubMed ID: 25482603
[TBL] [Abstract][Full Text] [Related]
17. Loss of functional prion protein: a role in prion disorders?
Borchelt DR; Sisodia SS
Chem Biol; 1996 Aug; 3(8):619-21. PubMed ID: 8807894
[TBL] [Abstract][Full Text] [Related]
18. No influence of amyloid-beta-degrading neprilysin activity on prion pathogenesis.
Glatzel M; Mohajeri MH; Poirier R; Nitsch RM; Schwarz P; Lu B; Aguzzi A
J Gen Virol; 2005 Jun; 86(Pt 6):1861-1867. PubMed ID: 15914866
[TBL] [Abstract][Full Text] [Related]
19. A Neuronal Culture System to Detect Prion Synaptotoxicity.
Fang C; Imberdis T; Garza MC; Wille H; Harris DA
PLoS Pathog; 2016 May; 12(5):e1005623. PubMed ID: 27227882
[TBL] [Abstract][Full Text] [Related]
20. Reduction of prion infectivity and levels of scrapie prion protein by lithium aluminum hydride: implications for RNA in prion diseases.
Jeong BH; Kim NH; Jin JK; Choi JK; Lee YJ; Kim JI; Choi EK; Carp RI; Kim YS
J Neuropathol Exp Neurol; 2009 Aug; 68(8):870-9. PubMed ID: 19606066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
